These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 18656800)

  • 1. Which factors predict the recovery of natural heart function after insertion of a left ventricular assist system?
    Mano A; Nakatani T; Oda N; Kato T; Niwaya K; Tagusari O; Nakajima H; Funatsu T; Hashimoto S; Komamura K; Hanatani A; Ueda IH; Kitakaze M; Kobayashi J; Yagihara T; Kitamura S
    J Heart Lung Transplant; 2008 Aug; 27(8):869-74. PubMed ID: 18656800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy.
    Hetzer R; Müller JH; Weng YG; Loebe M; Wallukat G
    J Thorac Cardiovasc Surg; 2000 Nov; 120(5):843-53. PubMed ID: 11044309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in B-type natriuretic peptides after surgical ventricular restoration.
    Sartipy U; Albåge A; Larsson PT; Insulander P; Lindblom D
    Eur J Cardiothorac Surg; 2007 May; 31(5):922-8. PubMed ID: 17321144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index is a useful predictor of prognosis after left ventricular assist system implantation.
    Mano A; Fujita K; Uenomachi K; Kazama K; Katabuchi M; Wada K; Terakawa N; Arai K; Hori Y; Hashimoto S; Nakatani T; Kitamura S
    J Heart Lung Transplant; 2009 May; 28(5):428-33. PubMed ID: 19416769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience of weaning from left ventricular assist system in an acutely-ill patient with dilated cardiomyopathy and severe left ventricular dysfunction: a case report].
    Fujimura M; Komamura K; Sasaki T; Nakatani S; Yasumura Y; Yamagishi M; Miyatake K; Tsukada T; Sasako Y; Nakatani T
    J Cardiol; 1998 Jan; 31(1):31-6. PubMed ID: 9488949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure.
    Frantz RP; Olson LJ; Grill D; Moualla SK; Nelson SM; Nobrega TP; Hanna RD; Backes RJ; Mookadam F; Heublein D; Bailey KR; Burnett JC
    Am Heart J; 2005 Mar; 149(3):541-7. PubMed ID: 15864245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who would be a candidate for bridge to recovery during prolonged mechanical left ventricular support in idiopathic dilated cardiomyopathy?
    Matsumiya G; Monta O; Fukushima N; Sawa Y; Funatsu T; Toda K; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):699-704. PubMed ID: 16153916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation.
    Frazier OH; Rose EA; Oz MC; Dembitsky W; McCarthy P; Radovancevic B; Poirier VL; Dasse KA;
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1186-95. PubMed ID: 11726895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial size and fibrosis changes during left ventricular assist device support.
    Yamada Y; Saito S; Nishinaka T; Yamazaki K
    ASAIO J; 2012; 58(4):402-6. PubMed ID: 22739784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of cardiac function after weaning from ventricular assist devices.
    Liang H; Lin H; Weng Y; Dandel M; Hetzer R
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1555-60. PubMed ID: 16307998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of sympathetic nerve activity in end-stage cardiomyopathy patients receiving left ventricular support.
    Miyagawa S; Sawa Y; Fukushima N; Nishimura M; Matsumiya G; Taketani S; Horiguchi K; Ohtake S; Matsuda H
    J Heart Lung Transplant; 2001 Nov; 20(11):1181-7. PubMed ID: 11704478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery.
    Xydas S; Rosen RS; Ng C; Mercando M; Cohen J; DiTullio M; Magnano A; Marboe CC; Mancini DM; Naka Y; Oz MC; Maybaum S
    J Heart Lung Transplant; 2006 Jan; 25(1):7-15. PubMed ID: 16399524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial changes in renal function as a prognostic indicator in advanced heart failure patients with left ventricular assist system.
    Iwashima Y; Yanase M; Horio T; Seguchi O; Murata Y; Fujita T; Toda K; Kawano Y; Nakatani T
    Ann Thorac Surg; 2012 Mar; 93(3):816-23. PubMed ID: 22364976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol.
    Nessler J; Nessler B; Kitliński M; Gackowski A; Piwowarska W; Stepniewski M
    Kardiol Pol; 2008 Feb; 66(2):144-51; discussion 152-3. PubMed ID: 18344152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Seghatol FF; Shah DJ; Diluzio S; Bello D; Johnson MR; Cotts WG; O'Donohue JA; Bonow RO; Gheorghiade M; Rigolin VH
    Am J Cardiol; 2004 Apr; 93(7):854-9. PubMed ID: 15050488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal prohormone brain natriuretic peptide plasma levels in heart failure are affected both directly and indirectly by carvedilol.
    Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
    Angiology; 2008; 59(3):323-8. PubMed ID: 18388105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist.
    Saito S; Matsumiya G; Sakaguchi T; Miyagawa S; Yamauchi T; Kuratani T; Sawa Y
    J Heart Lung Transplant; 2010 Jun; 29(6):672-9. PubMed ID: 20188595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First American experience with the Terumo DuraHeart left ventricular assist system.
    Griffith K; Jenkins E; Pagani FD
    Perfusion; 2009 Mar; 24(2):83-9. PubMed ID: 19654148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.